Jung Hyun Kwon
Overview
Explore the profile of Jung Hyun Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
1238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wi C, Ryu E, King K, Kwon J, Bublitz J, Park M, et al.
J Allergy Clin Immunol Glob
. 2025 Feb;
4(2):100409.
PMID: 40008091
Background: There is a significant delay between symptom onset and diagnosis of childhood asthma, but the impact of this delay on asthma outcomes has not been well understood. Objectives: We...
2.
Kim J, Kim S, Song D, Kim H, Yoon E, Park J, et al.
Ann Med
. 2025 Jan;
57(1):2428431.
PMID: 39856091
Background/aims: Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis...
3.
Yim H, Seo Y, Kim J, Kim W, Jung Y, Jang J, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39828249
Background/aims: Besifovir (BSV) showed comparable antiviral activity superior safety profiles to tenofovir disoproxil fumarate (TDF) in treatment-naïve chronic hepatitis B (CHB). However, no data are available regarding the antiviral efficacy...
4.
Kim J, Kim H, Tak K, Han J, Nam H, Sung P, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39743888
Background/aims: Hepatocellular carcinoma (HCC) exhibits significant sex disparities in incidence, yet its molecular mechanisms remain unclear. We explored the role of telomerase reverse transcriptase (TERT) genetic alterations and hepatitis B...
5.
Lee J, Nam S, Kwon J, Shim D, Baek S, Lee S
Sci Rep
. 2024 Nov;
14(1):26718.
PMID: 39496713
Thromboembolism, a serious complication in patients with liver abscesses, can lead to organ deterioration if left untreated. However, factors associated with thromboembolism in these patients remain poorly understood. We aimed...
6.
Lee S, Nam S, Han J, Kwon J
Cancers (Basel)
. 2024 Oct;
16(20).
PMID: 39456637
: Reliable biomarkers for predicting outcomes in hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (Ate/Bev) are still lacking. Cytokines, which play a crucial role in immune regulation and HCC...
7.
Lee S, Kwon J, Jang J, Bae S, Yoon S, Jung E, et al.
Transplantation
. 2024 Oct;
PMID: 39375899
Liver transplantation (LT) is the ultimate treatment for patients with end-stage liver disease or early hepatocellular carcinoma. In the context of LT, because of the unique immunological characteristics of human...
8.
Kim H, Kim J, Kim J, Han J, Lee S, Nam H, et al.
Liver Int
. 2024 Jul;
44(10):2753-2762.
PMID: 39073214
Background And Aims: Molecular processes driving immune-active chronic hepatitis B (CHB) with and without hepatitis B e antigen (HBeAg) remain incompletely understood. This study aimed to investigate expression profiles of...
9.
Yang K, Yang H, Kim C, Nam H, Kim J, Lee A, et al.
Gut Liver
. 2024 Jul;
18(5):877-887.
PMID: 39021227
Background/aims: Bile duct invasion (BDI) is rarely observed in patients with advanced hepatocellular carcinoma (HCC), leading to hyperbilirubinemia. However, the efficacy of pretreatment biliary drainage for HCC patients with BDI...
10.
Kang M, Lee S, Jang E, Park J, Seo D, Han J, et al.
Liver Transpl
. 2024 May;
30(9):877-886.
PMID: 38809243
While steroid therapy is the preferred treatment for severe alcohol-associated hepatitis, the role of effector regulatory T (eTreg) cells and their association with steroid response and clinical outcomes in these...